Success Metrics

Clinical Success Rate
78.6%

Based on 11 completed trials

Completion Rate
79%(11/14)
Active Trials
3(16%)
Results Posted
18%(2 trials)
Terminated
3(16%)

Phase Distribution

Ph phase_2
2
11%
Ph not_applicable
5
26%
Ph phase_4
5
26%

Phase Distribution

0

Early Stage

2

Mid Stage

5

Late Stage

Phase Distribution12 total trials
Phase 2Efficacy & side effects
2(16.7%)
Phase 4Post-market surveillance
5(41.7%)
N/ANon-phased studies
5(41.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

73.3%

11 of 15 finished

Non-Completion Rate

26.7%

4 ended early

Currently Active

3

trials recruiting

Total Trials

19

all time

Status Distribution
Active(3)
Completed(11)
Terminated(4)
Other(1)

Detailed Status

Completed11
Terminated3
Recruiting3
Withdrawn1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
19
Active
3
Success Rate
78.6%
Most Advanced
Phase 4

Trials by Phase

Phase 22 (16.7%)
Phase 45 (41.7%)
N/A5 (41.7%)

Trials by Status

terminated316%
withdrawn15%
recruiting316%
completed1158%
unknown15%

Recent Activity

Clinical Trials (19)

Showing 19 of 19 trials
NCT05699265

Cardiovasculorenal Phenotyping in Fabry Disease Through Noninvasive Testing

Terminated
NCT02577835

International Registry for Ambulatory Blood Pressure and Arterial Stiffness Telemonitoring

Completed
NCT04307004Not Applicable

Evaluating Novel Approaches for Estimating Awake and Sleep Blood Pressure

Completed
NCT03781401

Telemonitoring of Blood Pressure in Local Pharmacies

Recruiting
NCT03132129

Prevalence and Determinants of Subclinical Cardiovascular Dysfunction in Adults With Type 2 Diabetes Mellitus

Recruiting
NCT02670031

Response of the Myocardium to Hypertrophic Conditions in the Adult Population

Recruiting
NCT05264090Not Applicable

Possibilities of Interpreting the Night-to-Day Ratio Specified by 24-hour Blood Pressure Monitoring

Completed
NCT04553861

Smartwatch ABPM vs. Conventional ABPM

Completed
NCT02539953Not Applicable

Ambulatory Blood Pressure Monitoring in Rivaroxaban Therapy

Withdrawn
NCT03566654Phase 2

Clinical Trial on Remote Ischemic Conditioning and Hypertension(HOPE)

Unknown
NCT00741585Phase 4

Prognostic Value of the Circadian Pattern of Ambulatory Blood Pressure for Multiple Risk Assessment

Completed
NCT02653222Phase 2

Chemical Renal Ethanol Sympatholysis Under CT Guidance Use for the Control of Therapy-Resistant Hypertension

Terminated
NCT02003469Not Applicable

Preventing Outcomes Through Effective Cardiovascular Risk Reduction After Transplant II

Completed
NCT01716819Not Applicable

Role of the Renin Angiotensin Aldosterone System in the Mechanisms of Transition to Heart Failure in Abdominal Obesity

Completed
NCT00473174Phase 4

Comparison of Awakening Versus Bedtime Dosing of Ramipril in Subjects With Essential Hypertension

Completed
NCT00295542Phase 4

Ambulatory Blood Pressure Monitoring in the Prediction of Cardiovascular Events and Effects of Chronotherapy

Completed
NCT00302705Phase 4

Comparison of the Antihypertensive Efficacy of Valsartan and Enalapril After Missing One Dose

Completed
NCT00449618Phase 4

Comparison of Awakening Versus Bedtime Dosing of Aspirin in Pre-Hypertension or Mild Essential Hypertension

Terminated
NCT00298129

Autonomic Imbalance and 24-h Blood Pressure Change in Patients With Chronic Renal Disease

Completed

All 19 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
19